47 results about "Nasal Turbinate" patented technology

Sinusitis, enlarged nasal turbinates, tumors, infections, hearing disorders, allergic conditions, facial fractures and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches and, in many cases, flexible catheters as opposed to instruments having rigid shafts. Various diagnostic procedures and devices are used to perform imaging studies, mucus flow studies, air/gas flow studies, anatomic dimension studies, endoscopic studies and transillumination studies. Access and occluder devices may be used to establish fluid tight seals in the anterior or posterior nasal cavities/nasopharynx and to facilitate insertion of working devices (e.g., scopes, guidewires, catheters, tissue cutting or remodeling devices, electrosurgical devices, energy emitting devices, devices for injecting diagnostic or therapeutic agents, devices for implanting devices such as stents, substance eluting devices, substance delivery implants, etc.

Medializing the middle turbinate in the nose has been realized as a solution to the common complication of adhesions following nasal and sinus surgery. The invention provides a system for medializing the middle turbinate by attaching the middle turbinate temporarily to the nasal septum. The attachment is performed using a wafer with means on both sides for attaching the wafer to a mucosal surface. The attachment may also be performed using a tissue adhesive, pins, or other medical devices described herein. The invention also provides a system for attaching the uvula to the nasopharyngeal side of the soft palate. The invention provides a medical device for use in the inventive procedures as well as methods for the procedures and kits for use by a physician.

Apparatus and methods for the treatment of nasal tissue, particularly the nasal turbinates, are described herein. One method for reducing the size of the inferior nasal turbinate is to apply ultrasound energy to the tissue regions beneath the surface of the turbinate tissue. One instrument may be used to deliver ultrasound energy and to provide an infusion or injection of a fluid directly into the turbinate being treated. The injected fluid can be used to bulk up the size of the turbinate to ensure that the ultrasound energy is properly delivered directly into the intended turbinate tissue. Accordingly, fluids containing anesthetics, fluids infused with analgesics, etc. may be used for pain management while other medications, such as non-steroidal drugs, steroidal drugs, anti-inflammatory drugs, anti-histamines, anti-bacterial drugs, etc., can also be used.

Laser for thermal shrinkage of soft tissue of uvula, soft palate, nasal turbinate or tongue base for the treatment of snoring, nasal obstruction or sleep apnea are disclosed. The preferred laser includes infrared laser about 0.7 to 1.85 micron, pulse duration about 100 microsecond to 5 seconds, spot size of about 2 to 5 mm and power of about 2 to 20 W at the treated area. The laser energy is delivered to the treated area by an optical fiber and a hand piece to cause a localized temperature about 65 to 85 degree Celsius for sufficient shrinkage of the treated soft tissues. Optical fiber bundles to produce high-power diode laser output or multi-wavelength are also disclosed.

Devices, systems and methods are disclosed for modulating cranial nerves, such as the sphenopalatine ganglion, to treat a medical condition of a patient, such as cluster headache. A stimulation device is advanced transnasally to a target site at or adjacent to the nasopharyngeal mucosa posterior to the middle turbinate. Electrical impulses are applied through one or more electrodes in the stimulation device to the target nerve sufficient to modulate the nerve and treat the medical condition.

Devices and methods are provided which shield at least one turbinate from trauma or damage during sinus surgery that could be caused by direct contact with diagnostic and therapeutic devices. The devices and methods provided are particularly useful for protecting nasal turbinates during FESS and FTIS procedures.

To deliver a medication and its active ingredients to the esophagus, a nasal irrigator, which is capable of delivering medicated fluid that coats the whole nasal and paranasal sinus cavities, is used. The nasal irrigator forces an aerosol mist of the medicated fluid into the nasal cavity above the inferior turbinate, independent of a user's breathing in. Mucociliary clearance from the nasal cavity then delivers the medication to the throat and it is then topically introduced onto the esophagus over an extended period of time.

The invention provides a device and a method for recording respiratory sounds in exercising horses thereby enabling the user identify upper airway abnormalities and/or evaluate athletic potential by, e.g., measuring expiratory and/or inspiratory times during exercise under field and/or actual racing conditions. In particular, the invention provides a respiratory monitoring system or device in which a transducer or microphone is placed in direct contact with the skin of the subject animal overlying the skull, e.g., the frontal sinus or nasal turbinates and thereby enable recording and analysis of upper airway respiratory sound from the exercising animal. In one embodiment, the invention provides a device wherein the transducer or microphone is positioned or embedded within a gel pad or other suitable medium and the device placed in direct contact with the skin of the animal overlying, e.g., the skull, sinus or nasal turbinates of the horse The device of the invention provides an acoustic monitoring system capable of direct attachment to the head of a racing horse which produces an output signal that is not diluted, attenuated or otherwise corrupted by noises such as wind, hoof beats and/or treadmill noises.

A method to detect local antibodies such as antigen-specific IgE via a brush biopsy specimen of a mucosal surface of a subject is disclosed. The method is easily performed in an office setting on both adult and pediatric patients. Also disclosed is a brush device specially designed for harvesting materials from a mucosal surface such as the medial surface of the inferior turbinate.

The invention provides a novel traditional Chinese medicine orifice-opening rhinitis medicine and a using method thereof. The novel traditional Chinese medicine orifice-opening rhinitis medicine is prepared from radix angelicae, apricot kernels, euphorbia kansui, violet magnolia, catechu, asarum sieboldii, Chinese honeylocust fruit, cortex cinnamomi, ligusticum wallichii, fructus evodiae, radix aconiti carmichaeli, fructus xanthii, centipeda minima and an excipient. The novel traditional Chinese medicine orifice-opening rhinitis medicine is different from a traditional operative treatment and western medicine treatment mode, the size of the inferior nasal concha after the medicine is used is deceased by one third to one fourth compared with that of the hypertrophic inferior nasal concha before the medicine is used, the nasal obstruction symptom is effectively improved, the lower portion of the inferior nasal concha is slightly astringed to form the uniform and front-back consistent tensile force by taking the inferior turbinate bone as a fulcrum, therefore, the sinus ostia of the paranasal sinus naturally expand, pus smoothly flows out, and permanent nasal cavity ventilation and non-obstruction and paranasal sinus drainage non-obstruction are guaranteed. Accordingly, the advantages of being capable of retaining the structure, more minimally invasive and closer to the nasal normal physiologic structure are achieved, and the novel traditional Chinese medicine orifice-opening rhinitis medicine is free of an operation and pain, convenient to use, suitable for being used in various occasions and significant in effect.

The invention belongs to the field of Chinese and Western medicine preparations, in particular to a Bisukang preparation with an antihistamine inhibitor for decreasing permeability of capillary bloodvessels under nasal mucosa. The Bisukang preparation is prepared from the following components of fructus xanthii, flos magnoliae, radix angelicae dahurioae, herba asari, rhizoma chuanxiong, rhizoma coptidis, grape seed and chlortrimeton. The Chinese and Western medicine preparation has the advantages that the permeability of the capillary blood vessels under the nasal mucosa can be decreasing, and the functions of diminishing inflammation and resisting allergy are realized; the Chinese and Western medicine preparation is mainly used for treating rhinorrhea, rhinitis, nasosinusitis, paranasalsinusitis and hypertrophy of nasal turbinates, and also can reach good treatment effect on slight cough and headache caused by common cold; the Chinese medicine and western medicine are combined, theeffect is quickly taken, and the effect is good.

The invention relates to a pure traditional Chinese medicine preparation capable of rapidly and radically treating various types of rhinitis. The pure traditional Chinese medicine preparation is prepared from the following raw materials: freeze-dried aloe powder, cactus extract, saffron, fructus forsythiae, flos magnoliae liliflorae, radix scutellariae, rhizoma polygoni cuspidati, herba taraxaci,herba centipedae, ginseng flower, radix astragali, radix puerariae, radix saposhnikoviae, propolis extract, os draconis, radix glycyrrhizae, notoginseng flower and borneo camphor. The pure traditionalChinese medicine preparation can have a rapid and radical treatment effect on various types of rhinitis such as chronic sinusitis, allergic rhinitis, atrophic rhinitis, frontal sinusitis, hypertrophyof nasal turbinates and the like which cannot be treated with efficient drugs in medical profession at present and has no side effect, and sequelae are avoided. The pure traditional Chinese medicinepreparation is an externally used spray prepared from pure traditional Chinese medicines with the modern biopharmaceutical technology and is quite convenient to carry and use, safe and reliable. Trinity combined therapy is adopted for the pure traditional Chinese medicine preparation, functions of stuffing relieving, toxin expelling and repairing are combined organically, nasal mucosa is repairedrapidly, effects can be taken 3-5 min after the preparation is used, all symptoms can be eliminated generally when a patient is treated with the preparation for 7 d, and the patient can be cured afterone treatment course (25 d) with the preparation.

Devices and methods for creating a breathing passage and/or for maintaining a position of a septum. An exemplary device includes a base member, a first side member extending upward away from a first edge of the base member and being configured to contact a septum of a nasal cavity, and a second side member extending upward away from a second edge of the base member and being configured to contact a turbinate. The first and/or second side members are made of a flexible material. An exemplary method includes inserting a septum support into one side of a nasal cavity for creating a breathing passage, placing a first side member and a second side member of the septum support into contact with a septum and a turbinate, respectively. The first and second side members are biased away from one another such that pressure is applied to the septum.

The invention relates to a nose cover with hollow tube, which comprises a nose cover inside the nasal cavity, wherein the nose cover is adhered with the nasal cavity; it comprises one hollow tube at the lower nose channel of nasal cavity and one connector for connecting the nose cover and the hollow tube; said hollow tube has one bend tube with several detach packs and bend connecting ring; the bend tube is one tube bendable, to adjust the angle; and the bend connecting ring connects the detach packs to form the bend tube and adjust needed length; therefore, the user can adjust the length and angle when wearing it.

The invention provides a method for culturing middle turbinate derived olfactory ensheathing cells. The method comprises the following steps: firstly, carrying out two times of digestion on middle turbinate mucosa to remove blood cells and an epithelial layer; then carrying out primary culture on digested tissue blocks; carrying out first-time passage after the cells grow to a certain fusion degree; carrying out pressurized screening on first-generation cells and then removing a screening reagent; identifying after the cells grow to the certain fusion degree. The method for culturing the olfactory ensheathing cells has the advantages of no ethical problems, easiness for collecting tissue sources, high safety and the like. Finally, the obtained cells are of a 10<7> order of magnitude and the purity reaches the international same level; the method is suitable for scientific research experiments and pre-clinical researches. All reagents used by the method are common reagents and the costof the unit cell amount is relatively low.